What is next in ALS clinical trials?
- 21 August 2007
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 69 (8) , 719-720
Abstract
In the present issue, Miller et al. present the results of another unsuccessful clinical trial for the treatment of ALS.1 The present study is the latest of a number of phase II and III clinical trials completed …Keywords
This publication has 9 references indexed in Scilit:
- Phase II/III randomized trial of TCH346 in patients with ALSNeurology, 2007
- Development and evaluation of a self-administered version of the ALSFRS-RNeurology, 2006
- Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS modelNature Medicine, 2005
- Rating the severity of ALS by caregivers over the telephone using the ALSFRS‐RAmyotrophic Lateral Sclerosis, 2005
- An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutaseJournal of Neurochemistry, 2005
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003
- July 8 HighlightsNeurology, 2003
- Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosisApoptosis, 2002
- Disease progression in amyotrophic lateral sclerosis: Predictors of survivalMuscle & Nerve, 2002